Don’t let the high cost of brand cystinosis therapy disrupt your treatment. We help eligible patients access Cystagon (cysteamine bitartrate) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
Cystagon PAP for cystinosis patients.
Eligibility, nephrology/genetics/metabolic coordination.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$4,800 | Save substantially |
| CVS Pharmacy | ~$5,000 | Save substantially |
| Walmart | ~$3,200 | Save substantially |
| Costco | ~$3,100 | Save substantially |
Specialty Pharmacy | ~$3,500 | Save substantially |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
PAP at no cost.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Cystagon:
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Cystagon assistance.
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Cystagon (cysteamine bitartrate) is for nephropathic cystinosis — a rare autosomal recessive disorder of lysosomal cystine transport (CTNS gene). Untreated cystinosis causes progressive renal Fanconi syndrome, renal failure (typically by age 10 without treatment), growth retardation, hypothyroidism, neurologic complications, and other severe manifestations. Cysteamine reduces intracellular cystine accumulation and delays progression.
How Cystagon Works:
In cystinosis, defective cystinosin transporter prevents cystine export from lysosomes — cystine accumulates and damages cells throughout the body. Free cysteamine penetrates lysosomes and reacts with cystine to form a mixed disulfide (cysteine + cysteamine-cysteine) that can be exported via the intact lysine transporter.
Treatment with cysteamine reduces tissue cystine accumulation — delays/prevents progression of renal Fanconi syndrome, slows ESRD development, reduces complications. Treatment must be started as early as possible after diagnosis and continued for life. White blood cell cystine levels guide dose titration.
Form and use:
Cystagon every 6 hours by mouth — dosing schedule essential for steady cystine reduction. Capsules can be opened and contents mixed with food for young children. WBC cystine measurement every 3 months to guide dose. Lifelong therapy required.
Generic availability:
No generic. Procysbi (cysteamine bitartrate delayed-release) is twice-daily alternative — brand only, substantially more expensive but more convenient than every-6-hour Cystagon dosing. Topical cysteamine eye drops (Cystaran, Cystadrops) for corneal cystine crystals.
Warnings:
Common adverse effects: GI symptoms (nausea, vomiting, anorexia — sometimes dose-limiting), foul body/breath odor (sulfur smell — cysteamine metabolite), Ehlers-Danlos-like skin lesions/elastic fiber abnormalities (rare), neurologic symptoms (rare). Serious: rare hypersensitivity. Dose adjustments and supportive care often needed.
$3,000–$5,000/month. No generic. PAP at no cost; advocacy $69.95/month.
Same active drug (cysteamine bitartrate). Cystagon every 6 hours (including overnight); Procysbi twice daily (delayed-release). Procysbi much more convenient but substantially more expensive (often $50,000+/year). Insurance coverage varies.
Cysteamine has short half-life; continuous cystine depletion requires steady dosing. Missing doses allows cystine to re-accumulate. Strict adherence — including waking overnight — important for optimal outcomes.
Cystinosis Research Foundation (CRF) provides patient support, education, and research funding. cystinosisresearch.org
Most cystinosis patients eventually need kidney transplant by adolescence/early adulthood despite cysteamine therapy. Cysteamine continues post-transplant to protect other organs (cystine still accumulates in non-renal tissues).
GI symptoms manageable with food, antiemetics, dose adjustments. Body odor is unavoidable consequence of therapy but socially challenging. Chlorophyll tablets help some patients.
Limited data — discuss with metabolic specialist.
PAP, manufacturer copay, CRF (Cystinosis Research Foundation) connections, NORD.
If struggling with Cystagon cost, we can help — and connect with cystinosis foundations. Check eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.